Evidence map›Paper›PMID 29300312›Full record

ArticleNanomaterials (Basel, Switzerland)2018

In-Silico Design, Synthesis and Evaluation of a Nanostructured Hydrogel as a Dimethoate Removal Agent.

Fabian Avila-Salas, Adolfo Marican, Jorge Villaseñor, Mauricio Arenas-Salinas, Yerko Argandoña, Julio Caballero, Esteban F Durán-Lara

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Fabian Avila-SalasCentro de Nanotecnología Aplicada, Facultad de Ciencias, Universidad Mayor, Huechuraba 8580000, Chile. fabian.avila@umayor.cl.
Adolfo MaricanInstituto de Química de Recursos Naturales, Universidad de Talca, Talca 3460000, Chile. amarican@utalca.cl.
Jorge VillaseñorInstituto de Química de Recursos Naturales, Universidad de Talca, Talca 3460000, Chile. jvillase@utalca.cl.
Mauricio Arenas-SalinasCentro de Bioinformática y Simulación Molecular, Facultad de Ingeniería, Universidad de Talca, Talca 3460000, Chile. marenas@utalca.cl.ORCID 0000-0001-5143-1845
Yerko ArgandoñaCentro de Bioinformática y Simulación Molecular, Facultad de Ingeniería, Universidad de Talca, Talca 3460000, Chile. yargandona@utalca.cl.
Julio CaballeroCentro de Bioinformática y Simulación Molecular, Facultad de Ingeniería, Universidad de Talca, Talca 3460000, Chile. jcaballero@utalca.cl.ORCID 0000-0003-0182-1444
Esteban F Durán-LaraInstituto de Química de Recursos Naturales, Universidad de Talca, Talca 3460000, Chile. eduran@utalca.cl.ORCID 0000-0002-8796-6830

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study describes the in-silico design, synthesis, and evaluation of a cross-linked PVA hydrogel (CLPH) for the absorption of organophosphorus pesticide dimethoate from aqueous solutions. The crosslinking effectiveness of 14 dicarboxilic acids was evaluated through in-silico studies using semiempirical quantum mechanical calculations. According to the theoretical studies, the nanopore of PVA cross-linked with malic acid (CLPH-MA) showed the best interaction energy with dimethoate. Later, using all-atom molecular dynamics simulations, three hydrogels with different proportions of PVA:MA (10:2, 10:4, and 10:6) were used to evaluate their interactions with dimethoate. These results showed that the suitable crosslinking degree for improving the affinity for the pesticide was with 20% (

Indexed as

absorptionbiodegradablecross-linked PVA hydrogeldimethoatepesticide

Identifiers

PMID29300312
PMCPMC5791110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.